ENGLEWOOD, Colo.--(BUSINESS WIRE)--Qurate Retail, Inc. Declares Quarterly Cash Dividend on 8.0% Series A Cumulative Redeemable Preferred Stock.

Hauppauge, NY, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Cemtrex Inc. (NASDAQ: CETX, CETXP), an advanced security technology and industrial services company, has reported its financial and operational results for the fiscal first quarter ended December 31, 2024.

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Monolithic Power Systems Inc. (NASDAQ:MPWR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/monolithic-lawsuit-submission-form?prid=129696&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Transocean Ltd. (NYSE:RIG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transocean-ltd-lawsuit-submission-form?prid=129692&wire=1 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Nextracker Inc. (NASDAQ:NXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nextracker-inc-lawsuit-submission-form?prid=129697&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Edison International (NYSE:EIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edison-international-lawsuit-submission-form?prid=129698&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=129691&wire=1 or contact Joseph E. Levi, Esq.

Extensions support capital structure improvements and refinancing efforts Extensions support capital structure improvements and refinancing efforts

The S&P 500 has been a solid benchmark that has produced annualized double-digit returns for many years.

Day Hagan has listed a new ETF on the NYSE Arca today — the Day Hagan Smart Buffer ETF (DHSB). The actively managed fund offers exposure to U.S. equity markets while aiming to mitigate downside risk and provide upside potential.

Roku's fourth-quarter 2024 results benefit from consistent growth in streaming households and streaming hours on The Roku Channel.

CRNT's focus on growth initiatives, including mmW products, Private Networks and Managed Services, holds promise, but soft CSP market remains concern.

Solid funding commitments support Hercules Capital's Q4 earnings amid a decline in net investment income and higher operating expenses.

THOUSAND OAKS, Calif. , Feb. 14, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at Citi's 2025 Virtual Oncology Leadership Summit at 3:00 p.m.

NEW YORK , Feb. 14, 2025 /PRNewswire/ -- Translational Development Acquisition Corp. (NASDAQ: TDACU) (the "Company") announced today that the separate trading has commenced for its Class A ordinary shares and warrants that were included in units sold in the Company's initial public offering completed on December 24, 2024. Such Class A ordinary shares and warrants separately trade on The Nasdaq Global Market ("Nasdaq") under the symbols "TDAC" and "TDACW," respectively.

SAN FRANCISCO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases, today announced that on February 11, 2025, the company granted inducement awards to nine new employees. The grants were made pursuant to Nurix's 2024 Equity Inducement Plan as an inducement material to the employees' acceptance of employment with Nurix and were approved by the Compensation Committee of Nurix's Board of Directors in …

SAN DIEGO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that the Company will participate in the following upcoming investor conferences:

NEW YORK , Feb. 14, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ICON PLC ("ICON" or "the Company") (NASDAQ: ICLR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ICON securities between July 27, 2023 and October 23, 2024, both dates inclusive (the "Class Period").

SHENZHEN, China , Feb. 14, 2025 /PRNewswire/ -- MingZhu Logistics Holdings Limited ("MingZhu" or the "Company") (Nasdaq: YGMZ ), an elite provider of logistics and transportation services to businesses, today announced that on February 13, 2025, it received a letter from the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that the Nasdaq staff has determined to delist the Company's ordinary shares from The Nasdaq Capital Market (the "Delisting Determination"), because the bid price of the Company's listed securities has closed at less than $1 per share over the previous 30 consecutive business days, and therefore it no longer complies …

NEW YORK , Feb. 14, 2025 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Target Corporation ("Target" or "the Company") (NYSE: TGT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Target securities between August 26, 2022 and November 19, 2024, both dates inclusive (the "Class Period").